Topics

Bayer to file extended marketing authorization for Xarelto in children

05:20 EDT 9 Jul 2019 | SmartBrief

Bayer announced plans to seek approval for use of its blood thinner Xarelto, or rivaroxaban, for pediatric patients based on  -More

Original Article: Bayer to file extended marketing authorization for Xarelto in children

NEXT ARTICLE

More From BioPortfolio on "Bayer to file extended marketing authorization for Xarelto in children"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...